{"id":2527,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2006-02-10","marketCap":18.99167823791504,"name":"Acorda Therapeutics Inc","phone":"19143474300","outstanding":1.2400000095367432,"symbol":"ACOR","website":"https://www.acorda.com/","industry":"Biotechnology"},"price":14.99085,"year":2023,"month":12,"day":23,"weekday":"Saturday","title":"Ownership Structure of Acorda Therapeutics Inc Stock","date":"2023-12-23","url":"/posts/2023/12/23/ACOR","content":[{"section":"Major Institutional Shareholders","text":"As of the latest filing, Vanguard Group Inc. is the largest institutional shareholder, owning approximately 9.33% of Acorda Therapeutics Inc stock. Other major institutional shareholders include BlackRock Inc. with a stake of 8.06%, and Dimensional Fund Advisors LP with a stake of 7.54%."},{"section":"Insider Ownership","text":"Insiders also have a significant ownership stake in Acorda Therapeutics Inc. CEO Ron Cohen holds approximately 2.52% of the company's stock, while CFO David Lawrence owns around 0.37%. Other notable insiders with ownership stakes include Chief Medical Officer Enrique Carrazana (0.10%) and Chief Scientific Officer Burkhard Blank (0.09%)."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1702896029,"headline":"Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Shares Bounce 53% But Its Business Still Trails The Industry","id":124585911,"image":"https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","symbol":"ACOR","publisher":"Yahoo","summary":"Acorda Therapeutics, Inc. ( NASDAQ:ACOR ) shareholders are no doubt pleased to see that the share price has bounced 53...","url":"https://finance.yahoo.com/news/acorda-therapeutics-inc-nasdaq-acor-104029667.html"}]}